Overview

A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Analgesics